image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Crest Nicholson

January 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRST
  • Price:
  • 203p
Crest Nicholson has guided to a slight reduction in pretax profit forecasts from £50m to £45m-£50m, citing higher build costs at its Farnham site. This is partially offset by higher savings of £3m achieved. Clearly, market conditions remain challenging although Crest still has a strong balance sheet with net cash expected to be c. £65m at the year-end. Excluding bulk sales, the sales per outlet per week was 0.39 for the last ten weeks, an improvement on the 0.25 in the seven weeks ended 21 August, but down from the 0.55 seen this time last year. New eps forecasts are for 13.5p for the year ended October, and 11.3p in FY’24. On a price / tangible net asset value the shares trade on a lowly 0.5x. A hold for recovery, pote ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X